Vos G J, Moloo S K, Nelson R T, Gardiner P R
International Laboratory for Research on Animal Diseases, Nairobi, Kenya.
Parasitology. 1988 Dec;97 ( Pt 3):383-92. doi: 10.1017/s0031182000058807.
Attempts were made to immunize goats by infection with large numbers of metacyclic trypanosomes of a clone of Trypanosoma vivax, followed by chemotherapy. Five groups of 6 goats each were infected intradermally with 5 different doses of cultured metacyclics of T. vivax, ranging from 10(2) to 10(6) trypanosomes/goat. Four weeks after infection, the goats were treated with 10 mg/kg diminazene aceturate (Berenil, Hoechst A.G.). Three weeks after treatment, 3 goats in each group were challenged intradermally with 10(4) homologous metacyclics derived from culture. The remaining 3 goats in each group were challenged by 20 tsetse infected with the homologous clone. Five out of 30 goats were resistant to homologous challenge; 4 of the goats that had been challenged with culture parasites, and 1 that had been challenged by tsetse. In each group 1 goat was protected. Protection was therefore not apparently influenced by the number of trypanosomes used to establish the primary infection. In another experiment, 6 goats were each infected by feeding 100 tsetse on the goats for 15 consecutive days. Three weeks after infection the goats were treated with Berenil and 3 weeks later challenged by 20 tsetse infected with the homologous clone. Three out of the 6 goats resisted challenge. The susceptible goats in both experiments, however, showed a reduction in the peak of parasitaemia following challenge compared with both challenge controls and the initial infections. Lytic antibodies to cultured metacyclics of T. vivax were detected in goats that resisted challenge after a primary infection with cultured metacyclics, and in resistant and susceptible goats after a primary infection by tsetse. All infected goats produced lytic antibodies to live bloodstream forms, as well as antibodies to bloodstream form lysates (demonstrated by ELISA). It is suggested that the immunity that had been induced in some of the experimental animals is due to antibody responses to both metacyclic and bloodstream variable antigen types (VATs) expressed during infection.
尝试通过用大量间日疟原虫克隆的循环后期锥虫感染山羊,随后进行化学疗法来使其免疫。将30只山羊分成5组,每组6只,分别皮内注射5种不同剂量的间日疟原虫培养的循环后期锥虫,剂量范围为每只山羊10²至10⁶个锥虫。感染四周后,给山羊注射10mg/kg的乙酰氨基阿苯达唑(贝尼尔,赫斯特股份公司)。治疗三周后,每组3只山羊皮内接种来自培养物的10⁴个同源循环后期锥虫进行攻击。每组其余3只山羊通过20只感染了同源克隆的采采蝇进行攻击。30只山羊中有5只对同源攻击具有抗性;其中4只曾用培养的寄生虫进行攻击,1只曾用采采蝇进行攻击。每组中有1只山羊受到保护。因此,保护作用显然不受用于建立初次感染的锥虫数量的影响。在另一项实验中,6只山羊每只连续15天被100只采采蝇叮咬感染。感染三周后,给山羊注射贝尼尔,三周后用20只感染了同源克隆的采采蝇进行攻击。6只山羊中有3只抵抗了攻击。然而,与攻击对照和初次感染相比,两个实验中的易感山羊在攻击后的寄生虫血症峰值均有所降低。在用培养的循环后期锥虫进行初次感染后抵抗攻击的山羊中,以及在用采采蝇进行初次感染后的抗性和易感山羊中,均检测到了针对间日疟原虫培养的循环后期锥虫的溶细胞抗体。所有感染的山羊均产生了针对活血流形式的溶细胞抗体,以及针对血流形式裂解物的抗体(通过ELISA证实)。有人认为,一些实验动物中诱导产生的免疫力是由于对感染期间表达的循环后期和血流可变抗原类型(VATs)的抗体反应所致。